Niagen Bioscience, Stock Market Value
| NAGE Stock | 6.48 0.11 1.67% |
| Symbol | Niagen |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Niagen Bioscience,. If investors know Niagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Niagen Bioscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Niagen Bioscience, is measured differently than its book value, which is the value of Niagen that is recorded on the company's balance sheet. Investors also form their own opinion of Niagen Bioscience,'s value that differs from its market value or its book value, called intrinsic value, which is Niagen Bioscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Niagen Bioscience,'s market value can be influenced by many factors that don't directly affect Niagen Bioscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Niagen Bioscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Niagen Bioscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Niagen Bioscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Niagen Bioscience, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Niagen Bioscience,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Niagen Bioscience,.
| 06/09/2024 |
| 12/31/2025 |
If you would invest 0.00 in Niagen Bioscience, on June 9, 2024 and sell it all today you would earn a total of 0.00 from holding Niagen Bioscience, or generate 0.0% return on investment in Niagen Bioscience, over 570 days. Niagen Bioscience, is related to or competes with Olema Pharmaceuticals, Corvus Pharmaceuticals, Prothena Plc, Ventyx Biosciences, Keros Therapeutics, Akebia Ther, and Rigel Pharmaceuticals. More
Niagen Bioscience, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Niagen Bioscience,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Niagen Bioscience, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 10.16 | |||
| Value At Risk | (4.07) | |||
| Potential Upside | 3.8 |
Niagen Bioscience, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Niagen Bioscience,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Niagen Bioscience,'s standard deviation. In reality, there are many statistical measures that can use Niagen Bioscience, historical prices to predict the future Niagen Bioscience,'s volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (1.86) |
Niagen Bioscience, Backtested Returns
Niagen Bioscience, has Sharpe Ratio of -0.0867, which conveys that the firm had a -0.0867 % return per unit of risk over the last 3 months. Niagen Bioscience, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Niagen Bioscience,'s Standard Deviation of 2.46, mean deviation of 1.93, and Risk Adjusted Performance of (0.05) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.12, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Niagen Bioscience,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Niagen Bioscience, is expected to be smaller as well. At this point, Niagen Bioscience, has a negative expected return of -0.21%. Please make sure to verify Niagen Bioscience,'s potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if Niagen Bioscience, performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.28 |
Weak reverse predictability
Niagen Bioscience, has weak reverse predictability. Overlapping area represents the amount of predictability between Niagen Bioscience, time series from 9th of June 2024 to 21st of March 2025 and 21st of March 2025 to 31st of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Niagen Bioscience, price movement. The serial correlation of -0.28 indicates that nearly 28.0% of current Niagen Bioscience, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.28 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 5.0 |
Niagen Bioscience, lagged returns against current returns
Autocorrelation, which is Niagen Bioscience, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Niagen Bioscience,'s stock expected returns. We can calculate the autocorrelation of Niagen Bioscience, returns to help us make a trade decision. For example, suppose you find that Niagen Bioscience, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Niagen Bioscience, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Niagen Bioscience, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Niagen Bioscience, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Niagen Bioscience, stock over time.
Current vs Lagged Prices |
| Timeline |
Niagen Bioscience, Lagged Returns
When evaluating Niagen Bioscience,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Niagen Bioscience, stock have on its future price. Niagen Bioscience, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Niagen Bioscience, autocorrelation shows the relationship between Niagen Bioscience, stock current value and its past values and can show if there is a momentum factor associated with investing in Niagen Bioscience,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Niagen Bioscience, is a strong investment it is important to analyze Niagen Bioscience,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Niagen Bioscience,'s future performance. For an informed investment choice regarding Niagen Stock, refer to the following important reports:Check out Niagen Bioscience, Correlation, Niagen Bioscience, Volatility and Niagen Bioscience, Alpha and Beta module to complement your research on Niagen Bioscience,. For information on how to trade Niagen Stock refer to our How to Trade Niagen Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Niagen Bioscience, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.